Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


3 Acta Haematol
2 Blood
1 Cancer Chemother Pharmacol
1 Eur J Haematol
1 Exp Cell Res
1 Exp Hematol
2 Genes Chromosomes Cancer
2 Int J Hematol
1 J Clin Oncol
9 Leuk Lymphoma
3 Leuk Res
10 Leukemia
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Haematol

  1. SANTOPIETRO M, Miano M, Palumbo G, Zhang K, et al
    Atypical Chronic Myeloid Leukemia in a Patient with Aplastic Anemia.
    Acta Haematol. 2019 May 21:1-2. doi: 10.1159/000497137.
    PubMed     Text format    

    Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data.
    Acta Haematol. 2019 May 21:1-3. doi: 10.1159/000496449.
    PubMed     Text format    

  3. ZENG Z, Liu W, Benton CB, Konoplev S, et al
    Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2019 May 21:1-9. doi: 10.1159/000495456.
    PubMed     Text format     Abstract available


  4. ZHU HH, Hu J, Lo Coco F, Jin J, et al
    The Simpler the Better: Oral Arsenic for Acute Promyelocytic Leukemia.
    Blood. 2019 May 21. pii: blood.2019000760. doi: 10.1182/blood.2019000760.
    PubMed     Text format     Abstract available

  5. JONES CL, Stevens BM, D'Alessandro A, Culp-Hill R, et al
    Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
    Blood. 2019 May 17. pii: blood.2019898114. doi: 10.1182/blood.2019898114.
    PubMed     Text format     Abstract available

    Cancer Chemother Pharmacol

  6. LEI M, Liu L, Wu D
    Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro.
    Cancer Chemother Pharmacol. 2019 May 21. pii: 10.1007/s00280-019-03857.
    PubMed     Text format     Abstract available

    Eur J Haematol

  7. ABRUZZESE E, de Fabritiis P, Trawinska MM, Niscola P, et al
    Back to the future: Treatment-free remission and pregnancy in chronic myeloid leukemia.
    Eur J Haematol. 2019;102:197-199.
    PubMed     Text format    

    Exp Cell Res

  8. MORAD SAF, MacDougall MR, Abdelmageed N, Kao LP, et al
    Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
    Exp Cell Res. 2019 May 18. pii: S0014-4827(19)30262.
    PubMed     Text format     Abstract available

    Exp Hematol

  9. ANDERSON E, Rees B, Hull J, Heywood J, et al
    Intracellular cytarabine triphosphate in circulating blasts post-treatment predicts remission status in patients with acute myeloid leukemia.
    Exp Hematol. 2019 May 2. pii: S0301-472X(19)30191.
    PubMed     Text format     Abstract available

    Genes Chromosomes Cancer

  10. MACIEL ALT, Poubel CP, Noronha EP, Pombo-de-Oliveira MS, et al
    CRLF2 expression associates with ICN1 stabilization in T-cell acute lymphoblastic leukemia.
    Genes Chromosomes Cancer. 2019;58:396-401.
    PubMed     Text format     Abstract available

  11. DE SMITH AJ, Lavoie G, Walsh KM, Aujla S, et al
    Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
    Genes Chromosomes Cancer. 2019 May 18. doi: 10.1002/gcc.22765.
    PubMed     Text format     Abstract available

    Int J Hematol

  12. TYAGI A, Pramanik R, Bakhshi R, Singh A, et al
    Expression of mitochondrial genes predicts survival in pediatric acute myeloid leukemia.
    Int J Hematol. 2019 May 22. pii: 10.1007/s12185-019-02666.
    PubMed     Text format     Abstract available

  13. YANG JL, Liu YN, Bi YY, Wang H, et al
    ARID5B gene polymorphisms and the risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Int J Hematol. 2019 May 20. pii: 10.1007/s12185-019-02658.
    PubMed     Text format     Abstract available

    J Clin Oncol

  14. SAVONA MR, Wei AH
    Incorporating Precision BH3 Warheads Into the Offensive Against Acute Myeloid Leukemia.
    J Clin Oncol. 2019 May 21:JCO1900400. doi: 10.1200/JCO.19.00400.
    PubMed     Text format    

    Leuk Lymphoma

  15. SHIMAZU Y, Nohgawa M
    Plasma exchange following mogamulizumab therapy before bone marrow transplantation in refractory adult T-cell leukemia-lymphoma.
    Leuk Lymphoma. 2019 May 20:1-2. doi: 10.1080/10428194.2019.1616188.
    PubMed     Text format    

  16. INNOCENTI I, Morelli F, Autore F, Tomasso A, et al
    Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax.
    Leuk Lymphoma. 2019 May 20:1-3. doi: 10.1080/10428194.2019.1612063.
    PubMed     Text format    

  17. DURAND M, Lacaria K, Sidsworth M, Davis MK, et al
    Management of cardiovascular health in acute leukemia: a national survey.
    Leuk Lymphoma. 2019 May 21:1-11. doi: 10.1080/10428194.2019.1613539.
    PubMed     Text format     Abstract available

  18. PUN CC, Lee KK, Chui YL
    C-terminal BRE inhibits cellular proliferation and increases sensitivity to chemotherapeutic drugs of MLL-AF9 acute myeloid leukemia cells.
    Leuk Lymphoma. 2019 May 21:1-9. doi: 10.1080/10428194.2019.1616184.
    PubMed     Text format     Abstract available

  19. TORMO M, Gimenez E, Calabuig M, Talaya A, et al
    Cytomegalovirus DNAemia in patients with de novo acute myeloid leukemia undergoing cytotoxic chemotherapy.
    Leuk Lymphoma. 2019 May 21:1-3. doi: 10.1080/10428194.2019.1613541.
    PubMed     Text format    

  20. BEST S, Liu T, Bruss N, Kittai A, et al
    Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells.
    Leuk Lymphoma. 2019 May 21:1-5. doi: 10.1080/10428194.2019.1616190.
    PubMed     Text format     Abstract available

  21. JOSEPH R, McRee AJ, Mathews S, Zeidner JF, et al
    Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET).
    Leuk Lymphoma. 2019 May 23:1-5. doi: 10.1080/10428194.2019.1612060.
    PubMed     Text format    

  22. CATTANEO C, Gramegna D, Malagola M, Pagani C, et al
    Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.
    Leuk Lymphoma. 2019 May 23:1-7. doi: 10.1080/10428194.2019.1613535.
    PubMed     Text format     Abstract available

  23. KLOOS RQH, Pieters R, van den Bos C, van Eijkelenburg NKA, et al
    The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 May 23:1-9. doi: 10.1080/10428194.2019.1613537.
    PubMed     Text format     Abstract available

    Leuk Res

  24. CHIRON D, Jego G, Pellat-Deuceunynck C
    Corrigendum to 'Toll-like receptors Expression and involvement in Multiple Myeloma' [Leukemia Research 34 (2010)1545-1550].
    Leuk Res. 2019;81:106.
    PubMed     Text format    

  25. FANG J, Zhang R, Wang H, Hong M, et al
    Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [L
    Leuk Res. 2019;81:107.
    PubMed     Text format    

  26. JAMY O, Sarmad R, Costa L
    Risk and outcomes of second malignant neoplasms in chronic myeloid leukemia survivors.
    Leuk Res. 2019;82:1-6.
    PubMed     Text format     Abstract available


  27. KOTANI S, Yoda A, Kon A, Kataoka K, et al
    Molecular pathogenesis of disease progression in MLL-rearranged AML.
    Leukemia. 2019;33:612-624.
    PubMed     Text format     Abstract available

  28. PAN J, Niu Q, Deng B, Liu S, et al
    CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia.
    Leukemia. 2019 May 20. pii: 10.1038/s41375-019-0488.
    PubMed     Text format     Abstract available

  29. DAVER N, Schlenk RF, Russell NH, Levis MJ, et al
    Targeting FLT3 mutations in AML: review of current knowledge and evidence.
    Leukemia. 2019;33:299-312.
    PubMed     Text format     Abstract available

  30. KAMPEN KR, Sulima SO, Verbelen B, Girardi T, et al
    The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
    Leukemia. 2019;33:319-332.
    PubMed     Text format     Abstract available

  31. ENGEL N, Rovo A, Badoglio M, Labopin M, et al
    European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
    Leukemia. 2019;33:508-517.
    PubMed     Text format     Abstract available

  32. CERNA K, Oppelt J, Chochola V, Musilova K, et al
    MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells.
    Leukemia. 2019;33:403-414.
    PubMed     Text format     Abstract available

  33. BORGA C, Park G, Foster C, Burroughs-Garcia J, et al
    Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis.
    Leukemia. 2019;33:333-347.
    PubMed     Text format     Abstract available

  34. HOURIGAN CS, Gale RP, Walter RB
    Refining AML outcome prediction.
    Leukemia. 2019;33:283-284.
    PubMed     Text format    

  35. HERNANDEZ-SANCHEZ M, Kotaskova J, Rodriguez AE, Radova L, et al
    CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase.
    Leukemia. 2019;33:518-558.
    PubMed     Text format    

  36. KONG G, You X, Wen Z, Chang YI, et al
    Downregulating Notch counteracts Kras(G12D)-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.
    Leukemia. 2019;33:671-685.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  37. SCHIAVON V, Duchez S, Branchtein M, How-Kit A, et al
    Microenvironment tailors nTreg structure and function.
    Proc Natl Acad Sci U S A. 2019;116:6298-6307.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.